Zobrazeno 1 - 10
of 62
pro vyhledávání: '"Qiming Liao"'
Publikováno v:
IEEE Geoscience and Remote Sensing Letters. 19:1-5
Publikováno v:
Statistics in Biopharmaceutical Research. 14:592-601
In oncology clinical trials, characterizing the long-term overall survival (OS) benefit for an experimental treatment is often unobservable if some patients in the control group switch to drugs in ...
Publikováno v:
Optics Letters. 48:1742
Conventional optical fibers have good light conduction and transmission properties, and have been widely used in the fields of long-distance fiber-optic communication and sensing. However, due to the dielectric properties of the fiber core and claddi
Autor:
Yang Chen, Yili Chen, Xiaoyu Huang, Yikai Li, Yonghua Lao, Xuecheng Huang, Shaoqun Zhang, Qiming Liao
Publikováno v:
BioMed Research International
BioMed Research International, Vol 2021 (2021)
BioMed Research International, Vol 2021 (2021)
Object. Use a fluid-structure interaction (FSI) model to do a safety risk assessment of cervical spinal manipulative therapy (cSMT) for atherosclerosis to study the biomechanical changes of atherosclerosis plaque and the carotid artery (CA) lumen dur
Publikováno v:
4th International Conference on Informatics Engineering & Information Science (ICIEIS2021).
Publikováno v:
Optics Express. 29:38904
A plasmonic fiber-tip based on the metallic metasurface and the multimode fiber (MMF) alleviates the limitation of the inevitable large sensing size caused by fiber side wall functionalization. Localized surface plasmon resonance (LSPR) based on meta
Autor:
Cindy J. Bednasz, Charles S. Venuto, Qing Ma, Eric S. Daar, Paul E. Sax, Margaret A. Fischl, Ann C. Collier, Kimberly Y. Smith, Camlin Tierney, Edward P. Acosta, Donald E. Mager, Gene D. Morse, Hector H. Bolivar, Sandra Navarro, Susan L. Koletar, Diane Gochnour, Edward Seefried, Julie Hoffman, Judith Feinberg, Michelle Saemann, Kristine Patterson, Donna Pittard, David Currin, Kerry Upton, Michael Saag, Graham Ray, Steven Johnson, Bartolo Santos, Connie A. Funk, Michael Morgan, Brenda Jackson, Pablo Tebas, Aleshia Thomas, Ge-Youl Kim, Michael K. Klebert, Jorge L. Santana, Santiago Marrero, Jane Norris, Sandra Valle, Gary Matthew Cox, Martha Silberman, Sadia Shaik, Ruben Lopez, Margie Vasquez, Demetre Daskalakis, Christina Megill, Todd Stroberg, Jessica Shore, Babafemi Taiwo, Mitchell Goldman, Molly Boston, Jeffrey Lennox, Carlos del Rio, Timothy W. Lane, Kim Epperson, Annie Luetkemeyer, Mary Payne, Barbara Gripshover, Dawn Antosh, Jane Reid, Mary Adams, Sheryl S. Storey, Shelia B. Dunaway, Joel Gallant, Ilene Wiggins, Joan A. Swiatek, Joseph Timpone, Princy Kumar, Ardis Moe, Maria Palmer, Jon Gothing, Joanne Delaney, Kim Whitely, Ann Marie Anderson, Scott M. Hammer, Michael T. Yin, Mamta Jain, Tianna Petersen, Roberto Corales, Christine Hurley, Keith Henry, Bette Bordenave, Amanda Youmans, Mary Albrecht, Richard B. Pollard, Abimbola Olusanya, Paul R. Skolnik, Betsy Adams, Karen T. Tashima, Helen Patterson, Michelle Ukwu, Lauren Rogers, Henry H. Balfour, Kathy A. Fox, Susan Swindells, Frances Van Meter, Gregory Robbins, Nicole Burgett-Yandow, Charles E. Davis, Colleen Boyce, William A. O’Brien, Gerianne Casey, Chiu-Bin Hsaio, Jeffrey L. Meier, Jack T. Stapleton, Donna Mildvan, Manuel Revuelta, Wafaa El Sadr, Avelino Loquere, Nyef El-Daher, Tina Johnson, Robert Gross, Kathyrn Maffei, Valery Hughes, Glenn Sturge, Deborah McMahon, Barbara Rutecki, Michael Wulfsohn, Andrew Cheng, Norbert Bischofberger, Lynn Dix, Qiming Liao
Publikováno v:
Antimicrobial Agents and Chemotherapy. 63
AIDS Clinical Trial Group study A5202 (ClinicalTrials.gov identifier {"type":"clinical-trial","attrs":{"text":"NCT00118898","term_id":"NCT00118898"}}NCT00118898) was a phase 3b, randomized, partially blinded equivalence study of open-label atazanavir
Autor:
Yili Chen, Shaoqun Zhang, Yang Chen, Yonghua Lao, Xuecheng Huang, Xiaoyu Huang, Qiming Liao, Yikai Li
Publikováno v:
BioMed Research International; 1/2/2021, Vol. 2021, p1-8, 8p
Autor:
John Radford, Steen Lisby, Xiaonan Hong, Michinori Ogura, Andrew Davies, Anton Hagenbeek, Sirpa Leppä, Matthew J. Matasar, María Dolores Caballero Barrigón, Kirit M. Ardeshna, Michael Fennessy, Bronno van der Holt, Gustaaf W. van Imhoff, Andrew McMillan, Jette Soenderskov Goerloev, Kazimierz Kuliczkowski, Qiming Liao, Won Seog Kim
Publikováno v:
Journal of Clinical Oncology, 35(5), 544-+. American Society of Clinical Oncology
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 35(5), 544-551. AMER SOC CLINICAL ONCOLOGY
Journal of clinical oncology, 35(5), 544-551. American Society of Clinical Oncology
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 35(5), 544-551. AMER SOC CLINICAL ONCOLOGY
Journal of clinical oncology, 35(5), 544-551. American Society of Clinical Oncology
Purpose We compared the efficacy of ofatumumab (O) versus rituximab (R) in combination with cisplatin, cytarabine, and dexamethasone (DHAP) salvage treatment, followed by autologous stem-cell transplantation (ASCT) in patients with relapsed or refrac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1883184954a9424cc31697e23c6902eb
https://pure.eur.nl/en/publications/604044b9-4b63-488a-8f48-cb0010aa2db2
https://pure.eur.nl/en/publications/604044b9-4b63-488a-8f48-cb0010aa2db2
Autor:
Rajendra P. Singh, Matthew J. Matasar, Michael Fennessy, Doug Fecteau, Steen Lisby, Izidore S. Lossos, Qiming Liao, Thomas C. Shea, Klaus Edvardsen, Luis Fayad, Roxanne C. Jewell, Robin Joyce, Mohamed A. Kharfan-Dabaja, Craig H. Moskowitz, Kristen Henkel, Maria Alma Rodriguez, Myron S. Czuczman, Gary Spitzer
Publikováno v:
Blood. 122:499-506
Standard treatment of transplant-eligible patients with relapsed diffuse large B-cell lymphoma (DLBCL) consists of rituximab and platinum-based chemotherapy, either ifosfamide, carboplatin, and etoposide (ICE) or dexamethasone, cytarabine, and cispla